Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NUVL Nuvalent, Inc.

盘后交易 09-26 18:37:55 EDT

101.05

+0.60

+0.60%

盘后101.05

+0.000.00%

16:49 EDT

最高103.42	最低100.50	成交量75.54万
今开100.82	昨收100.45	日振幅2.91%
总市值65.48亿	流通市值33.27亿	总股本6,480万
成交额7,681万	换手率2.29%	流通股本3,292万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NUVL","market":"US","secType":"STK","nameCN":"Nuvalent, Inc.","latestPrice":101.05,"timestamp":1727380800000,"preClose":100.45,"halted":0,"volume":755380,"hourTrading":{"tag":"盘后","latestPrice":101.05,"preClose":101.05,"latestTime":"16:49 EDT","volume":456348,"amount":46113965.4,"timestamp":1727383757035},"delay":0,"floatShares":32923895,"shares":64797603,"eps":-2.798883,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.6,"latestTime":"09-26 18:37:55 EDT","open":100.82,"high":103.42,"low":100.5,"amount":76805346.3488,"amplitude":0.029069,"askPrice":107.09,"askSize":100,"bidPrice":95.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.798883,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1727395200000},"adr":0,"listingDate":1627531200000,"adjPreClose":100.45,"postHourTrading":{"tag":"盘后","latestPrice":101.05,"preClose":101.05,"latestTime":"16:49 EDT","volume":456348,"amount":46113965.4,"timestamp":1727383757035},"volumeRatio":0.833959,"impliedVol":0.432,"impliedVolPercentile":0.0556},"requestUrl":"/m/hq/s/NUVL","defaultTab":"news","newsList":[{"id":"2469711145","title":"Nuvalent, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469711145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469711145?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:03","pubTimestamp":1727103798,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时03分，Nuvalent, Inc.股票出现波动，股价大幅下挫5.03%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为250.66%、46.15%、43.90%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Black Diamond Therapeutics, Inc.，振幅分别为42.83%、42.78%、25.84%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230319a1dbf055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230319a1dbf055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NUVL"],"gpt_icon":0},{"id":"2469366701","title":"ESMO 2024｜挑战“地狱难度”，冒险家与biotech精神","url":"https://stock-news.laohu8.com/highlight/detail?id=2469366701","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469366701?lang=zh_cn&edition=full","pubTime":"2024-09-23 09:39","pubTimestamp":1727055553,"startTime":"0","endTime":"0","summary":"年初的ASCO大会上，洛拉替尼的CROWN研究随访数据引起了广泛关注。然而，洛拉替尼可能没有预见到，尽管其数据表现卓越，但并未能完全阻止竞争者的涌现；相反，潜在的挑战者迅速崛起。在9月份的ESMO大会上，新型ALK抑制剂NVL-655公布了其疗效和安全性的最新数据。这也许正是我们常说的biotech精神，也是国内生物技术企业需要学习和借鉴的。在此次ESMO大会上，Nuvalent展示了其人体1期试验的更新数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/240667","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["PFS","BK4539","BK4097","NUVL","BK4139","BK4195","BK4211","OS"],"gpt_icon":0},{"id":"2468857986","title":"Nuvalent, Inc.盘中异动 股价大涨5.04%报107.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468857986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468857986?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:02","pubTimestamp":1726768967,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时02分，Nuvalent, Inc.股票出现波动，股价大幅拉升5.04%。截至发稿，该股报107.80美元/股，成交量44.959万股，换手率0.64%，振幅5.00%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020248a1db39ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020248a1db39ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2468235237","title":"Nuvalent, Inc.盘中异动 大幅下挫5.05%报106.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468235237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468235237?lang=zh_cn&edition=full","pubTime":"2024-09-17 21:31","pubTimestamp":1726579868,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日21时31分，Nuvalent, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报106.51美元/股，成交量17.9081万股，换手率0.28%，振幅2.64%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917213108956ab36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917213108956ab36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL","BK4539","BK4139"],"gpt_icon":0},{"id":"1123397215","title":"异动解读 | 股票增发引发估值担忧 Nuvalent股价盘前大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123397215","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123397215?lang=zh_cn&edition=full","pubTime":"2024-09-17 20:30","pubTimestamp":1726576223,"startTime":"0","endTime":"0","summary":"生物制药公司Nuvalent周一晚间宣布以100美元/股的价格增发500万股股票,募资5亿美元。这一增发价格较上一次交易价112.17美元折价10.8%,引发了市场对公司估值的担忧。\n\n消息公布后,Nuvalent股价周二盘前大跌5.01%,至108.89美元。此前该股周一曾大涨28.2%,创下历史新高,主要是因公司公布了其癌症疗法临床试验乐观数据。\n\n分析人士指出,虽然增发有助于公司筹集发展资金,但定价过低可能会引发投资者对公司前景的质疑,加上股价已经大涨,出现获利了结行为也在情理之中。目前公司市值约为73亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NUVL"],"gpt_icon":0},{"id":"2468353180","title":"BUZZ-生物制药公司 Nuvalent 在增发 5 亿美元股票后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2468353180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468353180?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:46","pubTimestamp":1726573584,"startTime":"0","endTime":"0","summary":"    9月17日 - ** Nuvalent公司  股价盘前下跌2.9%，至108.89美元。** 生物制药公司周一晚些时候宣布  以 100 美元的价格发行 500 万股，筹资 5 亿美元。** 交易规模从 3.5 亿美元扩大到 5 亿美元，定价比股票最后一次交易折价 10.8** NUVL 公司公布了其癌症疗法 NVL-655 早期研究的乐观数据  后，周一股价大涨 28.2%，收盘价达到 112.17 美元，创下历史新高。** 根据伦敦证券交易所的数据，该公司拥有约 6480 万股已发行股票，市值约为 73 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU1496350171.SGD","LU0320765489.SGD","LU1363072403.SGD","LU0310799852.SGD","LU0496365809.HKD","LU0267386448.USD","IE00BFXG1179.USD","NUVL","BK4139","IE00BHPRN162.USD","LU0256863811.USD","LU0211331839.USD","LU0976567544.SGD","LU1032466523.USD","IE00B775SV38.USD","BK4566","BK4504","IE00BJTD4V19.USD","LU0323591593.USD","BK4207","LU0971096721.USD","LU1496350502.SGD","IE00BKVL7J92.USD","LU0211328371.USD","LU1084165304.USD","LU0070302665.USD","BK4581","LU1267930490.SGD","LU0215105999.USD","IE00BJTD4N35.SGD","LU1668664300.SGD","BK4585","IE00B1XK9C88.USD","LU1064131342.USD","LU","BK4516","BK4550","LU0211327993.USD","LU0149725797.USD","IE0034235188.USD","LU0203345920.USD","LU1162221912.USD","BK4588","LU0882574139.USD","IE000M9KFDE8.USD","LU0238689110.USD","LU1244550494.USD","LU0170899867.USD","LU1119994496.HKD"],"gpt_icon":0},{"id":"2468847510","title":"BUZZ--美国股票走势-Charles Schwab、CACI International、Icahn Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468847510?lang=zh_cn&edition=full","pubTime":"2024-09-17 00:07","pubTimestamp":1726502845,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 科技股周一拖累了标普500指数和纳斯达克指数，因为在本周晚些时候美联储将做出关键的货币政策决定之前，市场谨慎情绪弥漫，大多数交易商认为借贷成本将大幅下降。美东时间11:31，道琼斯工业平均指数  上涨0.19%，报41,470.55点。标普500指数  下跌0.17%，报5616.5点；纳斯达克综合指数  下跌0.79%，报17544.279点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEP","SBT","BLDR","CVX","REE","UPST","KLXE","ZNTL","MOS","FDX","APA","WYNN","NUVL","CZR","MGM","CSLR","HUT","COIN","UDR","SQQQ","AVB",".IXIC","YELP","LSCC",".SPX","ESS",".DJI","QLD","SYF","UDOW","LVS","DJX","CACI","DPZ","NQmain","ICE","QID","SCHW","MNQmain","COP","EOG","ALLY","ZG","ITOS","DOG","EQR"],"gpt_icon":1},{"id":"2467848578","title":"BUZZ--美国股票走势-博士伦、美国铝业、加密股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2467848578","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467848578?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:21","pubTimestamp":1726492860,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 美国主要股指周一开盘涨跌不一，因为在美联储本周晚些时候将做出关键的货币政策决定之前，华尔街开始变得谨慎，大多数交易员认为借贷成本将大幅下调。美东时间9:04，道指电子盘  上涨0.21%，报41513 点。标普500指数小型股  下跌0.08%，报5625.5点；纳斯达克100指数小型股  下跌0.48%，报19436点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDR","LVS","EQR","LU2023250504.SGD","BK4007","ALLY","ITOS","MGM","LU1599440770.SGD","CZR","BK4503","SG9999013999.USD","ZG","CL","BLDR","LU1917777945.USD","BK4515","HUT","LU0310800965.SGD","BK4150","NUVL","ZNTL","LU0980610538.SGD","BK4018","LU2237443382.USD","UPST","LU1883839398.USD","WYNN","BLCO","ICE","IE00B19Z3B42.SGD","AA","BK4512","LU0323591593.USD","RIOT","LU1153585028.USD","BK4550","LU0868494617.USD","AVB","BK4504","LU0130517989.USD","COIN","SG9999001176.USD","LU0052756011.USD","ESS","FDX","LU0081259029.USD"],"gpt_icon":1},{"id":"2467812207","title":"BUZZ-因癌症治疗数据前景看好，券商上调 PT 值，Nuvalent 公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467812207","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467812207?lang=zh_cn&edition=full","pubTime":"2024-09-16 20:33","pubTimestamp":1726490014,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更新)    9月16日 - ** 疗法开发商Nuvalent   股价盘前上涨22.3%至106.99美元，如果涨势保持，开盘价有望创下历史新高 ** 至少四家券商上调该股的预测价格 ** 该公司上周末在欧洲肿瘤内科学会大会上公布了其实验性癌症疗法NVL-655的最新早期数据** Guggenheim 将该公司的预测价格从 99 美元上调至 105","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PT","BK4139","NUVL","BK4539","BK4166"],"gpt_icon":0},{"id":"2467119688","title":"BUZZ-Nuvalent 在券商上调 PT 后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467119688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467119688?lang=zh_cn&edition=full","pubTime":"2024-09-16 19:48","pubTimestamp":1726487284,"startTime":"0","endTime":"0","summary":"    9月16日 - ** 疗法开发商Nuvalent   股价盘前上涨20%至105美元 ** 至少四家券商上调股票交易价格 ** 该公司上周末在欧洲肿瘤内科学会大会上公布了其实验性癌症疗法NVL-655的最新早期数据** 古根海姆将该公司的预测价格从 99 美元上调至 105 美元，股票评级为 \"买入\"；古根海姆称，更新后的数据应能增强投资者对 NVL-655 的信心，使其成为一种潜在的一流疗法；古根海姆还补充说，该疗法还能使全球可寻址市场从约 20 亿美元增长到超过 40 亿美元的长期市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","NUVL","PT","BK4139","BK4539"],"gpt_icon":0},{"id":"2467896852","title":"美国研究综述-Avalonbay Communities、Elf Beauty、Evercore","url":"https://stock-news.laohu8.com/highlight/detail?id=2467896852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467896852?lang=zh_cn&edition=full","pubTime":"2024-09-16 15:19","pubTimestamp":1726471184,"startTime":"0","endTime":"0","summary":"    路透9月16日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括Avalonbay Communities、Elf Beauty 和 Evercore 。要闻              * Avalonbay Communities Inc   ：摩根大通将目标价从212美元上调至247美元             * Elf Beauty Inc   ：Piper Sandler将目标价从260美元下调至162美元             * Evercore Inc   ：CFRA将其目标价从 \"买入 \"下调至 \"持有  * GE Vernova   ：汇丰银行将目标价从215美元上调至240美元  以下是路透周一报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEV","PGR","LU1242518931.SGD","BK4166","ELME","LU2355687059.USD","IE00B4JS1V06.HKD","IE00BJJMRY28.SGD","RC","LU1481011671.HKD","BK4182","INVH","BK4588","EVR","LU1064131342.USD","RKT","BK4595","ELF","LU1242518857.USD","BK4183","LU1481011911.USD","VRE","ONIT","BK4211","BK4215","UDR","BK4139","ESS","BK4023","AMH","LU0053671581.USD","IE00BFSS7M15.SGD","LU1718418525.SGD","ALLY","SG9999004303.SGD","MSTR","EQR","LU0731783394.SGD","CPT","BK4228","LU0742537680.HKD","PFSI","LU1983260115.SGD","IE00BZ1G4Q59.USD","TCBI","NUVL","RITM","IE0005OL40V9.USD","COOP","AVB"],"gpt_icon":1},{"id":"2464329959","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464329959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464329959?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":"    路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻    * Array Technologies Inc   ：杰富瑞维持 \"买入 \"评级，目标价11美元。* Nextracker Inc   ：杰富瑞给予 \"持有 \"评级，目标价46美元             * Nuvalent Inc   ：摩根大通将目标价从90美元上调至100美元             * 西方石油公司  ：Susquehanna 将目标价从 81 美元下调至 78 美元             * Onestream Inc   ：Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXT","BKNG","LEN","LU1093756168.USD","FSLR","MGY","MITK","ABNB","MRO","GEV","ARRY","ENPH","FLNC","FRPT","ASND","CTRA","HES","NUVL","LRMR","EOG","LU0154245673.USD","LU0348723411.USD","FNF","GWRE","COP","ASAN","BK4519","AFCG","OS","LU1988902786.USD","ORKA","LU0823414478.USD","ATHA","CDP","LU0082616367.USD","FAF","LU","LU0053666078.USD","BBIO","CASY","LU0130102774.USD","STZ","GTLB","AMRC","APA","LU1992135472.HKD","DVN","HASI","FANG"],"gpt_icon":1},{"id":"2464299513","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464299513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464299513?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":"    路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻    * Array Technologies Inc   ：杰富瑞维持 \"买入 \"评级，目标价11美元。* Nextracker Inc   ：杰富瑞给予 \"持有 \"评级，目标价46美元             * Nuvalent Inc   ：摩根大通将目标价从90美元上调至100美元             * 西方石油公司  ：Susquehanna 将目标价从 81 美元下调至 78 美元             * Onestream Inc   ：Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNC","MRO","EOG","OXY","ARRY","APA","CASY","BBIO","HES","AFCG","MITK","ABNB","BK4519","MGY","ENPH","LU0053666078.USD","DVN","GEV","FSLR","ASAN","LU0823414478.USD","LU","NUVL","ATHA","LU1992135472.HKD","ASND","OS","FRPT","LU0130102774.USD","LU1988902786.USD","HASI","LU0348723411.USD","ORKA","LU0154245673.USD","STZ","FAF","CDP","CTRA","BKNG","NXT","FANG","AMRC","GTLB","FNF","GWRE","COP","LRMR","LU0082616367.USD","LU1093756168.USD","LEN"],"gpt_icon":0},{"id":"2461453005","title":"Nuvalent, Inc.盘中异动 急速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461453005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461453005?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:44","pubTimestamp":1724435046,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日01时44分，Nuvalent, Inc.股票出现波动，股价快速上涨5.35%。截至发稿，该股报87.44美元/股，成交量19.6557万股，换手率0.30%，振幅5.39%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824014406ab5f7134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824014406ab5f7134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2461876288","title":"Nuvalent, Inc.盘中异动 快速拉升5.25%报80.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461876288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461876288?lang=zh_cn&edition=full","pubTime":"2024-08-22 00:53","pubTimestamp":1724259220,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日00时53分，Nuvalent, Inc.股票出现异动，股价大幅上涨5.25%。截至发稿，该股报80.31美元/股，成交量13.0634万股，换手率0.20%，振幅5.40%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200534097199811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082200534097199811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":1},{"id":"2460241812","title":"Nuvalent, Inc.2024财年第二财季实现净利润-57.17百万美元，同比减少96.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241812","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241812?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824038,"startTime":"0","endTime":"0","summary":"8月17日，Nuvalent, Inc.公布财报，公告显示公司2024财年第二财季净利润为-57.17百万美元，同比减少96.53%；其中营业收入为0.00美元，每股基本收益为-0.88美元。从资产负债表来看，Nuvalent, Inc.总负债38.19百万美元，其中短期债务0.00美元，资产负债比为0.18，流动比率为0.18。机构评级：截至2024年8月17日，当前有10家机构对Nuvalent, Inc.目标价做出预测，其中目标均价为102.20美元，其中最低目标价为90.00美元，最高目标价为115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006139f31b15f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006139f31b15f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUVL"],"gpt_icon":0},{"id":"2459323559","title":"Nuvalent, Inc.盘中异动 急速上涨5.09%报73.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459323559","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459323559?lang=zh_cn&edition=full","pubTime":"2024-08-13 01:35","pubTimestamp":1723484158,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日01时35分，Nuvalent, Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报73.55美元/股，成交量9.2423万股，换手率0.14%，振幅6.94%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013558aefe6f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013558aefe6f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2457739638","title":"Nuvalent, Inc.盘中异动 下午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457739638","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457739638?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:13","pubTimestamp":1723054429,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时13分，Nuvalent, Inc.股票出现波动，股价大幅下挫5.17%。截至发稿，该股报67.48美元/股，成交量17.7072万股，换手率0.27%，振幅5.13%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为2.28%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080802135098e34cf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080802135098e34cf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","NUVL"],"gpt_icon":0},{"id":"2456282854","title":"Nuvalent, Inc.盘中异动 大幅下挫5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456282854","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456282854?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:32","pubTimestamp":1722605535,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时32分，Nuvalent, Inc.股票出现异动，股价急速下挫5.62%。Nuvalent, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Moleculin Biotech, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为268.79%、57.64%、17.90%，振幅较大的相关个股有Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Coya Therapeutics, Inc.，振幅分别为22.02%、17.87%、14.08%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213216aefcf85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213216aefcf85f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NUVL","BK4139"],"gpt_icon":0},{"id":"2456653654","title":"Nuvalent, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456653654","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456653654?lang=zh_cn&edition=full","pubTime":"2024-08-02 03:07","pubTimestamp":1722539261,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日03时07分，Nuvalent, Inc.股票出现异动，股价快速跳水5.05%。Nuvalent, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Immuneering Corporation涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2952.22%、385.34%、219.05%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited，振幅分别为59.30%、57.88%、43.37%。Nuvalent, Inc.公司简介：Nuvalent Inc是一家临床阶段的生物制药公司，专注于为癌症患者创造精准靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802030741aefcbbf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802030741aefcbbf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvalent.com","stockEarnings":[{"period":"1week","weight":-0.0212},{"period":"1month","weight":0.1938},{"period":"3month","weight":0.3051},{"period":"6month","weight":0.3377},{"period":"1year","weight":1.3871},{"period":"ytd","weight":0.365}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvalent, Inc.于2017年1月25日根据特拉华州法律注册成立。他们是一家临床前阶段的生物制药公司，专注于为癌症患者创造精准的靶向治疗。他们的发现工作集中在激酶的小分子抑制剂上，这是一类可以在癌症生长和增殖中发挥核心作用的细胞靶标。特别是，他们专注于“临床证明”的激酶靶点，并且这些药物已经证明了足够的临床疗效和安全性数据，可以得到美国食品和药物管理局的批准并在临床环境中建立和使用。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.084747},{"month":2,"riseRate":1,"avgChangeRate":0.076205},{"month":3,"riseRate":0,"avgChangeRate":-0.105637},{"month":4,"riseRate":0.333333,"avgChangeRate":0.004859},{"month":5,"riseRate":0.333333,"avgChangeRate":0.001101},{"month":6,"riseRate":1,"avgChangeRate":0.229396},{"month":7,"riseRate":1,"avgChangeRate":0.110591},{"month":8,"riseRate":0.75,"avgChangeRate":0.277791},{"month":9,"riseRate":0.75,"avgChangeRate":-0.010152},{"month":10,"riseRate":1,"avgChangeRate":0.351145},{"month":11,"riseRate":0.333333,"avgChangeRate":0.016267},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.025299}],"exchange":"NASDAQ","name":"Nuvalent, Inc.","nameEN":"Nuvalent, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvalent, Inc.,NUVL,Nuvalent, Inc.股票,Nuvalent, Inc.股票老虎,Nuvalent, Inc.股票老虎国际,Nuvalent, Inc.行情,Nuvalent, Inc.股票行情,Nuvalent, Inc.股价,Nuvalent, Inc.股市,Nuvalent, Inc.股票价格,Nuvalent, Inc.股票交易,Nuvalent, Inc.股票购买,Nuvalent, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvalent, Inc.(NUVL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvalent, Inc.(NUVL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况